Riskpilot← Back to searchSign inGet full accessUnibio CIS ApS
APSActiveCVR 37456136Langebjerg 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 2016— employees
Revenue 2024
—
EBITDA margin
—
-11216% vs 2023
Equity ratio
-86.4%
Financial strength
Net profit 2024
DKK -2,2M
-2369% vs 2023
| Revenue | — | — |
| EBITDA | DKK -2,2M | -11216% |
| Net profit | DKK -2,2M | -2369% |
| Total assets | DKK 2,5M | +2% |
| Equity | DKK -2,1M | -3329% |
| Employees | — | — |
Legal name
Unibio CIS ApS
CVR number
37456136
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11. februar 2016
Share capital
DKK 50.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør i forening med en anden direktør.
Company purpose
Selskabets formål er forskning, udvikling, produktion, fabrikation, handel og andet i forbindelse hermed beslægtet virksomhed efter selskabets skøn.
Address
Langebjerg 1
Phone
+4563104040
Email
unibio@unibio.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 279 | 94 | -341 | -21 | -101 | -19 | -29 | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 279 | 94 | -341 | -21 | -101 | -19 | -29 | -19 | -2.150 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 279 | 94 | -341 | -21 | -101 | -19 | -29 | -19 | -2.150 |
| Net financials | 25 | -71 | 3 | 4 | -10 | 8 | 123 | -70 | -14 |
| Profit before tax | 304 | 23 | -338 | -17 | -111 | -11 | 94 | -89 | -2.164 |
| Tax | 67 | 5 | -75 | -4 | -24 | -3 | 72 | -0 | 33 |
| Net profit | 237 | 18 | -263 | -13 | -87 | -8 | 22 | -89 | -2.197 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6.798 | 2.276 | 2.251 | 2.285 | 2.022 | 2.228 | 2.502 | 2.408 | 2.466 |
| Equity | 287 | 305 | 42 | 29 | -59 | 8 | 155 | 66 | -2.131 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6.511 | 1.971 | 2.209 | 2.256 | 2.081 | 2.220 | 2.347 | 2.342 | 2.497 |
| Total debt | 6.511 | 1.971 | 2.209 | 2.256 | 2.081 | 2.220 | 2.347 | 2.342 | 2.497 |
EBITDA margin
-215000000.0%
This company
15.8%
Market median
-1360759594% vs market
20162024
Equity ratio
-86.4%
This company
38.2%
Market median
-326% vs market
20162024
Return on equity
-219700000.0%
This company
18.4%
Market median
-1194021839% vs market
20162024
Net profit margin
-219700000.0%
This company
8.1%
Market median
-2712345779% vs market
20162024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162024
Debt / equity
2.16×
This company
0.62×
Market median
-248% vs market
20162024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-02-11 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JH Management | Management | 2016 | — | — |
HB Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
JB Management | Management | 2018 | — | — |
LJ Management | Management | 2016 | — | — |
JD Management | Management | 2024 | — | — |
SO Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
UNIBIO A/S | Company | 100.0% | 100.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
UNIBIO A/S
Unibio CIS ApS Board members of Unibio CIS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Halling Pedersen | Management | 0 companies |
| Henrik Busch-Larsen | Chief Executive Officer | 0 companies |
| Jakob Brix Christensen | Management | 0 companies |
| Leif Jacobsen | Management | 0 companies |
| Jess Dragheim | Management | 0 companies |
| Søren Olrik Eklund | Chief Executive Officer | 0 companies |